TipRanks
Advertisement
Advertisement

DE:CBO0 Stock Latest News

Imunon Introduces Series B Preferred to Restructure Debt
Company AnnouncementsImunon Introduces Series B Preferred to Restructure Debt
15d ago
8K
IMNN
Imunon presents update on its IMNN-001 development program
PremiumThe Fly
Imunon presents update on its IMNN-001 development program
20d ago
IMNN
Imunon announces IDMC recommends continued Phase 2 development of IMNN-001
PremiumThe Fly
Imunon announces IDMC recommends continued Phase 2 development of IMNN-001
22d ago
IMNN
Imunon enters CRADA with National Cancer Institute for IMNN-001 development
PremiumThe Fly
Imunon enters CRADA with National Cancer Institute for IMNN-001 development
1M ago
IMNN
Imunon Earnings Call Highlights Survival Gains, Cash Needs
PremiumCompany Announcements
Imunon Earnings Call Highlights Survival Gains, Cash Needs
2M ago
IMNN
Imunon: Buy Rating Reiterated as Phase 3 IMNN-001 Progress and Extended Cash Runway Support Unchanged $10 Price Target
PremiumRatingsImunon: Buy Rating Reiterated as Phase 3 IMNN-001 Progress and Extended Cash Runway Support Unchanged $10 Price Target
2M ago
IMNN
Imunon Adopts New Equity-Based Executive Compensation Program
Premium
Company Announcements
Imunon Adopts New Equity-Based Executive Compensation Program
2M ago
8K
IMNN
Imunon reports Q2 EPS (54c), consensus (50c)
Premium
The Fly
Imunon reports Q2 EPS (54c), consensus (50c)
2M ago
IMNN
Imunon provides update on OVATION 3 trial of IMNN-001
PremiumThe Fly
Imunon provides update on OVATION 3 trial of IMNN-001
3M ago
IMNN
Imunon announces new preliminary data from IMNN-001 trial
PremiumThe Fly
Imunon announces new preliminary data from IMNN-001 trial
3M ago
IMNN
Imunon interim CFO Jeffrey Church to retire, Josh Blacher to succeed
PremiumThe Fly
Imunon interim CFO Jeffrey Church to retire, Josh Blacher to succeed
4M ago
IMNN
Imunon Names Josh Blacher Interim Chief Financial Officer
PremiumCompany Announcements
Imunon Names Josh Blacher Interim Chief Financial Officer
4M ago
8K
IMNN
Imunon announces IDMC recommendation for continuation of OVATION 3 trial
PremiumThe FlyImunon announces IDMC recommendation for continuation of OVATION 3 trial
4M ago
IMNN
Imunon Shareholders Expand Stock Incentive Plan, Back Governance
Premium
Company Announcements
Imunon Shareholders Expand Stock Incentive Plan, Back Governance
4M ago
8K
IMNN
Imunon Secures $10 Million Non-Dilutive Structured Financing
Premium
Company Announcements
Imunon Secures $10 Million Non-Dilutive Structured Financing
4M ago
8K
IMNN
Imunon Earnings Call Balances Breakthroughs and Cash Strain
PremiumCompany Announcements
Imunon Earnings Call Balances Breakthroughs and Cash Strain
5M ago
IMNN
Imunon’s Earnings Call Balances Survival Gains and Risks
PremiumCompany Announcements
Imunon’s Earnings Call Balances Survival Gains and Risks
5M ago
IMNN
Imunon reports Q1 EPS (84c), consensus ($1.28)
PremiumThe Fly
Imunon reports Q1 EPS (84c), consensus ($1.28)
5M ago
IMNN
Imunon Adopts Change-of-Control Severance Agreements for Executives
PremiumCompany Announcements
Imunon Adopts Change-of-Control Severance Agreements for Executives
5M ago
8K
IMNN
Imunon initiated with a Buy at Maxim
PremiumThe FlyImunon initiated with a Buy at Maxim
6M ago
IMNN
Imunon Earnings Call: Strong Data, Tight Cash Runway
Premium
Company Announcements
Imunon Earnings Call: Strong Data, Tight Cash Runway
6M ago
IMNN
Imunon announces final clinical data from OVATION 2 clinical trial
Premium
The Fly
Imunon announces final clinical data from OVATION 2 clinical trial
7M ago
IMNN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >